Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB25FCMZE
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,266
Award facts
- Contract value 100% obligated
- $4,265.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $4,265.80 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for NUCALA 100 mg/mL auto-injector medication, with an ultimate completion date of September 3, 2025. DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, specializing in supplying pharmaceutical products and medical supplies to federal agencies, particularly Department of Defense healthcare facilities. This delivery order was issued without a set-aside designation and represents performance at the vendor's Park Ridge location.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The underlying IDC, awarded under the SPE2DB program, enables the agency to procure a comprehensive range of pharmaceutical products including branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables to support military health facilities worldwide. DMS Pharmaceutical Group's role as a critical supplier in the federal pharmaceutical supply chain allows the Defense Logistics Agency to efficiently obtain specialized medications and auto-injectors, such as NUCALA, to meet the healthcare needs of military personnel and facilities.
Quick answers
Who was awarded contract SPE2DB25FCMZE?
SPE2DB25FCMZE was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 2, 2025.
How much is contract SPE2DB25FCMZE worth?
The government has obligated $4,266 on SPE2DB25FCMZE.
Is contract SPE2DB25FCMZE an order under another contract?
Yes. SPE2DB25FCMZE is a delivery order under SPE2DB24D9144, an indefinite delivery contract.
Was contract SPE2DB25FCMZE competed?
The extent of competition for SPE2DB25FCMZE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award